We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mutated Gene Found in Families with Multiple Tumors

By LabMedica International staff writers
Posted on 05 Oct 2015
Print article
Image: The replacement of the amino acid arginine by a cysteine at position 117 in POT1p.R117C produces conformational changes in the protein that are incompatible with an efficient connection to the telomere, inducing an aberrant telomere elongation and fragile telomeres in the mutated cells (Photo courtesy of CNIO).
Image: The replacement of the amino acid arginine by a cysteine at position 117 in POT1p.R117C produces conformational changes in the protein that are incompatible with an efficient connection to the telomere, inducing an aberrant telomere elongation and fragile telomeres in the mutated cells (Photo courtesy of CNIO).
Cardiac angiosarcoma (CAS) is a rare but malignant disease and in the case of hereditary CAS, the median survival expectancy is only four months because the disease is diagnosed at an advanced stage.

No genes responsible for CAS cases have been identified so far, thus hampering early diagnosis and effective treatment, which involves surgical excision combined with chemotherapy, and heart transplantation only for patients with no evidence for metastasis.

Scientists at the Spanish National Cancer Research Center (CNIO; Madrid, Spain), and their colleagues selected index cases from Li–Fraumeni-like (LFL) families negative for mutations and large deletions of the tumor protein 53 (TP53) gene. Three of the families had members affected with CAS plus other tumors. The rest of the families fulfilled the LFL criteria but they did not have any member with a CAS tumor. A group of 1,520 samples from a Spanish control population was used for genotyping the protection of telomeres 1(POT1) variant by denaturing high performance liquid chromatography.

The team used a multiplicity of techniques to find a novel damaging missense variant (p.R117C) in the POT1 gene in TP53-negative LFL families with CAS and other tumors. The discovery of the new mutation proved to be even more significant from a clinical perspective, given that it identified carriers at risk of developing cardiac angiosarcoma and possibly other tumors. The study confirms that POT1 plays a novel role in the development of different forms of hereditary cancer. The key is in the telomeres. When anomalies occur in the telomeres, the chromosomes become unstable, this, in turn, leads to extended genomic instability. POT1 is a central component of the telomeres that functions incorrectly when mutated.

Javier Benítez, PhD, a senior author of the study, said, “In the past, we simply didn't have anything that could help in identifying these people at risk, because there were no markers for familial CAS or for families with a syndrome similar to Li-Fraumeni without P53 mutations. This study uncovers one of the genes that explains the high incidence of cancer in some of them. The translation of these results into the clinic is immediate. In fact, we are already helping families that carry this mutation.” The study was published on September 25, 2015, in the journal Nature Communication.

Related Links:

Spanish National Cancer Research Center 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.